According to Wired, fitness tracker companies Oura and Whoop began offering blood panels as part of their subscription services this year, for an additional fee. Oura’s Health Panels test costs $99 and measures 50 biomarkers, while Whoop’s Advanced Labs starts at $349 for two tests per year and measures 65 biomarkers. A journalist tested both, booking through the apps and having blood drawn at Quest Diagnostics, with the companies covering the out-of-pocket costs. The tests are only available in the U.S., excluding Arizona, Hawaii, North Dakota, South Dakota, and Wyoming. Key findings included an alarmingly high lipoprotein(a) level from Oura’s test, indicating a genetic heart disease risk, and Whoop catching low iron and vitamin D levels that Oura missed.
The convenience is a bit of a myth
Here’s the thing: these companies bill this as a seamless, modern upgrade to clunky doctor-ordered labs. But is it really? If you have a primary care doctor—which, let’s be real, is a privilege in itself—getting labs done is often just part of the annual visit. You’re already there. The review found the app-booking process could be glitchy, requiring a printed PDF to avoid a wasted, hungry morning at the lab. So much for frictionless tech. It feels less like a revolution and more like creating a new, slightly annoying middleman for a service that already exists.
The data deluge and the doctor gap
Both tests provide a ton of data—way more than a standard doctor-ordered panel. That’s a double-edged sword. On one hand, you might catch something important, like that genetic heart risk flag. On the other, you’re handed a massive report full of numbers with zero immediate context. You get a “doctor-interpreted” report later, but in that moment, you’re alone with potentially scary information. Is more data always better? Or does it just create anxiety and a desperate Google search session before a professional can explain what it all means?
Where does this all go?
This feels like the start of a trend, not the endgame. Direct-to-consumer lab testing is clearly here to stay, and wearable companies want to be your holistic health dashboard. But I think the real future isn’t in replacing doctors—it’s in integrating this data *with* them. Whoop’s model, where you can upload doctor-ordered tests for free, seems smarter. It acknowledges the existing healthcare system instead of trying to awkwardly bypass it. The winner will be the platform that can seamlessly merge continuous sensor data (heart rate, sleep) with these periodic deep-dive biomarkers and then facilitate a conversation with a human clinician. Otherwise, we’re just paying for anxiety-inducing homework.
Actionable or just overwhelming?
The big question is: what do you *do* with all this? The review found an “easy, actionable fix” for low iron and vitamin D: a multivitamin. Great! But the scarier finding—the high lipoprotein(a)—is explicitly *not* actionable through lifestyle. It’s a genetic flag. So now you know you have a higher risk, but you can’t diet or exercise your way out of it. That knowledge has value, sure. But it also has a real psychological cost. These services sell empowerment, but sometimes they’re just selling a new kind of burden. Before you click “order,” ask yourself what you’re really looking for and if you’re prepared for answers you can’t easily change.
